Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
|Articles|September 25, 2006
Survey: Should HIV Tests Be Given Routinely?
Author(s)Consultantlive Staff
Atlanta -- The CDC recommended last week that HIV testing should become a routine part of office exams for all patients ages 13 to 64, irrespective of risk, without any pretest requirements. MedPage Today would like your opinion on this dramatic change in public health thinking.
Advertisement
Atlanta -- The CDC recommended last week that HIV testing should become a routine part of office exams for all patients ages 13 to 64, irrespective of risk, without any pretest requirements. MedPage Today would like your opinion on this dramatic change in public health thinking.
Read our article on this CDC announcement:
Advertisement
Related to this article
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
Advertisement
Advertisement
Trending on Patient Care Online
1
ACOG Issues Expanded Guideline on Managing Menopause-Related Vasomotor, Sleep, and Mood Symptoms
2
Who Should Get a CGM? Expanding the Primary Care Candidate Pool
3
FDA Grants Breakthrough Device Designation to Natera's Multi-Cancer Early Detection Blood Test
4
Mirikizumab Linked to Higher Rates of Corticosteroid-Free Composite Remission in UC and Crohn Disease
5